今天是:2019-12-12 星期四

Factors predicting recurrence after curative resection for rectal cancer: a 16-year study
下载XML文档

注册号:

Registration number:

ChiCTR1900022956 

最近更新日期:

Date of Last Refreshed on:

2019-05-05 

注册时间:

Date of Registration:

2019-05-05 

注册号状态:

补注册  

Registration Status:

Retrospective registration  

注册题目:

Factors predicting recurrence after curative resection for rectal cancer: a 16-year study 

Public title:

Factors predicting recurrence after curative resection for rectal cancer: a 16-year study 

注册题目简写:

 

English Acronym:

 

研究课题的正式科学名称:

Factors predicting recurrence after curative resection for rectal cancer 

Scientific title:

Factors predicting recurrence after curative resection for rectal cancer 

研究课题代号(代码):

Study subject ID:

 

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

 

申请注册联系人:

houssem ammar 

研究负责人:

ali ben ali 

Applicant:

houssem ammar 

Study leader:

ali ben ali 

申请注册联系人电话:

Applicant telephone:

+21 6 58133172 

研究负责人电话:

Study leader's telephone:

+21 6 22461254 

申请注册联系人传真 :

Applicant Fax:

 

研究负责人传真:

Study leader's fax:

 

申请注册联系人电子邮件:

Applicant E-mail:

hosshoss24@hotmail.fr 

研究负责人电子邮件:

Study leader's E-mail:

drhoussemammar@gmail.com 

申请单位网址(自愿提供):

Applicant website(voluntary supply):

 

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

 

申请注册联系人通讯地址:

11 rue la mer rouge, 4011 hammam sousse, tunisia 

研究负责人通讯地址:

LOT 303, rue de bruxelle, sahloul 3 ,sousse, TUNISIA 

Applicant address:

11 rue la mer rouge, 4011 hammam sousse, tunisia 

Study leader's address:

LOT 303, rue de bruxelle, sahloul 3 ,sousse, TUNISIA 

申请注册联系人邮政编码:

Applicant postcode:

 

研究负责人邮政编码:

Study leader's postcode:

 

申请人所在单位:

突尼斯萨鲁尔医院 

Applicant's institution:

Sahloul hospital 

是否获伦理委员会批准:

是 

Approved by ethic committee:

Yes 

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

萨鲁尔医院伦理委员会 

Name of the ethic committee:

Sahloul hospital ethic committe 

伦理委员会批准日期:

Date of approved by ethic committee:

 

伦理委员会联系人:

sahloul ethic committee hospital 

Contact Name of the ethic committee:

sahloul ethic committee hospital 

伦理委员会联系地址:

11 rue sahloul, 3011, sahloul hospital, Tunisia 

Contact Address of the ethic committee:

11 rue sahloul, 3011, sahloul hospital, Tunisia 

伦理委员会联系人电话:

Contact phone of the ethic committee:

 

伦理委员会联系人邮箱:

Contact email of the ethic committee:

 

研究实施负责(组长)单位:

we do not have a sponsor 

Primary sponsor:

we do not have a sponsor 

研究实施负责(组长)单位地址:

we do not have a sponsor 

Primary sponsor's address:

we do not have a sponsor 

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

突尼斯

省(直辖市):

苏斯市

市(区县):

苏斯市

Country:

Tunisia

Province:

Sousse

City:

sousse

单位(医院):

萨鲁尔医院

具体地址:

11 rue la centure, 3011

Institution
hospital:

Sahloul Hospital

Address:

11 rue la centure, 3011

经费或物资来源:

we do not receive any funds 

Source(s) of funding:

we do not receive any funds 

研究疾病:

rectal cancer 

Target disease:

rectal cancer 

研究疾病代码:

 

Target disease code:

 

研究类型:

基础科学研究 

Study type:

Basic Science 

研究所处阶段:

探索性研究/预试验 

Study phase:

研究目的:

The aim of this study was to identify the different prognostic factors in the recurrence of adenocarcinoma of the rectum. 

Objectives of Study:

The aim of this study was to identify the different prognostic factors in the recurrence of adenocarcinoma of the rectum. 

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

研究设计:

连续入组 

Study design:

Sequential 

纳入标准:

During the study period 188 patients underwent curative surgery for rectal adenocarcinoma, among which 53 had a recurrence.  

Inclusion criteria

During the study period 188 patients underwent curative surgery for rectal adenocarcinoma, among which 53 had a recurrence.  

排除标准:

patient who underwent non curative surgery or operated for other cancer than adenocarcinoma type. 

Exclusion criteria:

patient who underwent non curative surgery or operated for other cancer than adenocarcinoma type. 

研究实施时间:

Study execute time:

From2000-07-23To 2015-03-23 

干预措施:

Interventions:

组别:

caucasien

样本量:

88

Group:

caucasien

Sample size:

干预措施:

résection

干预措施代码:

Intervention:

résection

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

突尼斯 

省(直辖市):

苏斯市 

市(区县):

 

Country:

Tunisia 

Province:

sousse 

City:

 

单位(医院):

萨鲁尔医院 

单位级别:

 

Institution
hospital:

sahloul hospital  

Level of the institution:

 

测量指标:

Outcomes:

指标中文名:

pronostic

指标类型:

主要指标 

Outcome:

pronostic

Type:

Primary indicator 

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

rectum

Tissue:

epithelium

人体标本去向

使用后销毁 

说明

Fate of sample:

Destruction after use 

Note:

征募研究对象情况:

Recruiting status:

结束

Completed

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

N/A

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

盲法:

Blinding:

试验完成后的统计结果(上传文件):

点击下载

Calculated Results after
the Study Completed(upload file):

download

原始数据公开时间:

The time of sharing IPD:

试验完成后6个月内公开/Within six months after the trial complete

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

Not stated

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not stated

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

we do not have electronic data base , we use parer to sign in

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

we do not have electronic data base , we use parer to sign in

数据管理委员会:

Data Managemen Committee:

有/Yes

注册人:

Name of Registration:

 2019-05-05
返回列表